UNICA IRIS Institutional Research Information System

DONISI, CLELIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.265
NA - Nord America 1.361
AS - Asia 954
SA - Sud America 158
AF - Africa 26
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.769
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.796
US - Stati Uniti d'America 1.303
SG - Singapore 383
CN - Cina 326
SE - Svezia 144
BR - Brasile 130
DE - Germania 76
VN - Vietnam 73
GB - Regno Unito 47
IN - India 45
FI - Finlandia 40
FR - Francia 40
CA - Canada 34
NL - Olanda 33
KR - Corea 31
HK - Hong Kong 27
PL - Polonia 20
MX - Messico 18
AT - Austria 14
ES - Italia 11
IE - Irlanda 10
ZA - Sudafrica 10
EC - Ecuador 9
BE - Belgio 8
IQ - Iraq 7
IR - Iran 7
AR - Argentina 6
JP - Giappone 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
TR - Turchia 5
VE - Venezuela 5
AU - Australia 4
BD - Bangladesh 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
TH - Thailandia 4
AL - Albania 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
GR - Grecia 3
ID - Indonesia 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
GA - Gabon 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
SC - Seychelles 2
TN - Tunisia 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.769
Salva come PNG Salva come JPEG
Città #
Cagliari 17.597
Uta 987
Ashburn 242
Dallas 238
Singapore 187
Boardman 94
Nyköping 74
Beijing 67
Chandler 66
Los Angeles 55
New York 52
Fairfield 42
Hefei 40
Shanghai 34
Florence 33
Rome 31
Seoul 30
Ho Chi Minh City 29
Santa Clara 29
Munich 27
The Dalles 27
Hong Kong 24
Amsterdam 22
Helsinki 22
Seattle 22
Boston 20
Houston 19
Redondo Beach 18
Guangzhou 16
Nuremberg 16
Pune 15
Frankfurt am Main 14
Warsaw 14
Wilmington 14
Montreal 13
San Diego 13
Woodbridge 13
Cambridge 12
São Paulo 12
Toronto 12
Chennai 11
Hanoi 11
Chicago 10
Denver 10
Milan 10
Shenzhen 10
Düsseldorf 9
Lappeenranta 9
Stockholm 9
Buffalo 8
Dublin 8
London 8
Mexico City 8
Turku 8
Johannesburg 7
Orem 7
Paris 6
Poplar 6
Scandicci 6
Vienna 6
Bexley 5
Forlì 5
Haiphong 5
Menlo Park 5
Rio de Janeiro 5
Roubaix 5
San Francisco 5
Sassari 5
Selargius 5
Zhengzhou 5
Brooklyn 4
Brussels 4
Dong Ket 4
La Maddalena 4
Manila 4
Naples 4
Olbia 4
Phoenix 4
Portsmouth 4
Wroclaw 4
Wuhan 4
Ankara 3
Atlanta 3
Bishkek 3
Biên Hòa 3
Buenos Aires 3
Campinas 3
Charlotte 3
Clifton 3
Council Bluffs 3
Dubai 3
Guayaquil 3
Hangzhou 3
Islington 3
Joinville 3
Manchester 3
Naaldwijk 3
Osasco 3
Peristeri 3
Piscataway 3
Totale 20.610
Salva come PNG Salva come JPEG
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.718
New therapeutic targets in pancreatic cancer 1.593
Immunotherapy and Cancer: The Multi-Omics Perspective 1.557
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.308
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.184
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 1.006
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 946
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 905
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 901
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 744
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 715
Uncovering key targets of success for immunotherapy in pancreatic cancer 680
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 675
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 670
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 666
BRCA-mutant pancreatic ductal adenocarcinoma 584
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 577
Immune Checkpoint Inhibitors in the Treatment of HCC 552
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 531
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 514
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 511
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 437
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 416
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 253
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 175
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 154
Early taxane exposure and neurotoxicity in breast cancer patients 150
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 148
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 134
Exercise Prescription in Cardio-Oncology 75
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 69
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 67
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 59
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 57
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 53
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 51
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 47
Totale 21.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021693 0 0 0 0 0 205 58 116 47 116 76 75
2021/20221.168 69 63 4 29 60 100 61 89 77 116 228 272
2022/20233.703 325 526 339 242 270 296 202 311 297 407 314 174
2023/20243.429 159 117 113 184 273 553 549 245 243 239 368 386
2024/20259.999 2.859 3.319 854 923 453 645 423 58 99 119 76 171
2025/20261.857 297 243 400 345 300 272 0 0 0 0 0 0
Totale 21.882